Celine Dion faced a challenging hiatus from the stage last year as she grappled with "stiff-person" syndrome, an uncommon neurological disorder impacting her mobility and vocal abilities. Now, her sister Claudette Dion has revealed that Celine is struggling to control her muscles amid the ongoing battle with this rare condition.
Speaking to French publication 7 Jours, Claudette, a singer and the CEO/spokesperson for the Fondation Maman Dion, shared the difficulties they face with this little-known ailment. She expressed concern over the lack of awareness surrounding the disease, stating, "There are some who have lost hope because it is a disease that is not known." The Fondation Maman Dion, established by their mother, assists underprivileged children.
In a heartfelt revelation, Claudette mentioned the overwhelming support they receive at the foundation, with numerous calls expressing love and prayers for Celine. She highlighted the numerous messages, gifts, and blessed crucifixes sent to the singer, who, despite her diligent efforts, is grappling with a loss of muscle control. Claudette emphasized Celine's disciplined nature, making the situation even more poignant.
Stiff-person syndrome, also known as Moersch-Woltman syndrome, is described by the National Institute of Neurological Disorders and Stroke as a "rare neurological disorder with features of an autoimmune disease." It induces rigidity in the body, heightened sensitivity to stimuli like noise and touch, and can result in hunched postures.
Celine Dion publicly disclosed her diagnosis in December 2022, leading to the rescheduling of tour dates previously delayed due to the COVID-19 pandemic. By May 2023, she made the difficult decision to cancel the remaining dates of her global tour due to her health struggles.
Claudette shared the family's aspiration for Celine to return to the stage, but uncertainty looms large. She expressed sadness about the unique challenges posed by the rarity of the condition, stating, "Vocal cords are muscles, but so is the heart." With limited research on such one-in-a-million cases, the scientific community faces difficulties comprehending and addressing the intricacies of Celine's situation.
This is not the first time Celine Dion has faced health-related setbacks. In 2014, she confronted an illness causing inflammation in her throat muscles, coinciding with her responsibilities caring for her husband, Rene, who battled cancer and sadly passed away in 2016. The toll on her family during this period prompted the postponement of concerts from her Caesars Palace residency and the cancellation of Asia tour dates.
Stiff-person syndrome affects an estimated 1 in a million people, though some studies suggest this might be an underestimate. The disease disproportionately affects women, and associations with other autoimmune conditions such as Type 1 diabetes and vitiligo have been noted. While the exact cause remains elusive, research points towards a potential autoimmune response in the brain and spinal cord.
Management options include drugs to alleviate muscle spasms, antianxiety medications, and intravenous immunoglobulin treatment, involving the infusion of natural antibodies from healthy donors. Despite these potential avenues, the unpredictability of the disease and its impact on both muscles and vocal cords leave Celine's return to the stage uncertain.
In a rare public appearance in November, Celine Dion greeted members of the Montreal Canadiens NHL in Las Vegas, marking one of her few outings since revealing her diagnosis. The challenges she faces underscore the need for increased awareness and research to better understand and address stiff-person syndrome.
You must be logged in to post a comment.